Feasibility Study of CBCT for IGRT in Cancer Patients
Varian, a Siemens Healthineers Company
Varian, a Siemens Healthineers Company
University of Chicago
Boehringer Ingelheim
Hospices Civils de Lyon
Cancer Research UK
AstraZeneca
Washington University School of Medicine
Boehringer Ingelheim
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Varian, a Siemens Healthineers Company
I-Mab Biopharma US Limited
BicycleTx Limited
M.D. Anderson Cancer Center
British Columbia Cancer Agency
University of California, San Francisco
Bolt Biotherapeutics, Inc.
Kansas State University
RefleXion Medical
Abramson Cancer Center at Penn Medicine
Second Life Therapeutics
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoffmann-La Roche
Tempus AI
Revolution Medicines, Inc.
Inova Health Care Services
Cedars-Sinai Medical Center
Medical University of South Carolina
The New York Proton Center
University Health Network, Toronto
Taipei Veterans General Hospital, Taiwan
Celldex Therapeutics
Massachusetts General Hospital
Catalysis SL
IHU Strasbourg
University Hospital, Ghent
M.D. Anderson Cancer Center
Hoffmann-La Roche
Massachusetts General Hospital
Jules Bordet Institute
Revolution Medicines, Inc.
Abramson Cancer Center at Penn Medicine
Silverback Therapeutics
Albert Einstein College of Medicine
Hospices Civils de Lyon
University of Aarhus
IGF Oncology, LLC
University of Illinois at Chicago
Stanford University
Massachusetts General Hospital